You are here
David J. Sugarbaker, MD
Baylor College of Medicine, Lung Institute, and Division of Thoracic Surgery , Baylor St. Luke’s Medical Center, Houston, TX, USA
David Sugarbaker is a nationally and internationally recognized surgeon specializing in the treatment of mesothelioma. He is currently the Olga Keith Weiss Chair of Surgery at Baylor College of Medicine, Director of the newly formed Lung Institute, and Chief of the new Division of Thoracic Surgery at Baylor College of Medicine and Baylor St. Luke’s Medical Center in Houston, TX, USA.
Dr Sugarbaker attended Wheaton College in Wheaton, IL, USA, and then attended Cornell University Medical College in New York, NY, USA. He completed a residency at the Brigham and Women’s Hospital in Boston, MA, USA, and cardiothoracic training at the Toronto General Hospital and Mount Sinai Hospital in Toronto, Canada. In 1998, Dr Sugarbaker was appointed Chief of the newly formed Division of Thoracic Surgery at Brigham and Women's Hospital. Under his 25-year direction, the Division of Thoracic Surgery grew to become one of the largest in the nation
Dr Sugarbaker is known as a pioneer in the field of mesothelioma, having developed innovative multimodality therapies and directed translation research programs acclaimed worldwide. He has also developed new approaches to the treatment of cancer, and his technique of esophageal removal has been very widely adopted. He founded and directed the International Mesothelioma Program (IMP), which has become one of the largest mesothelioma programs in the world.
Dr Sugarbaker has published extensively, with more than 200 original papers and over 70 textbook chapters. His textbook on thoracic surgery entitled “Adult Chest Surgery” claimed several awards. Dr Sugarbaker has served as President of the prestigious American Association for Thoracic Surgery (AATS) and is currently the President of the AATS Graham Foundation for a second term.